SCHEMBL25859426

SCHEMBL25859426

C=Nc1cc(C)c(C)cc1CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21227827 0.76 TAAR1 (0.33) —
SCHEMBL19337478 0.76 TAAR1 (0.37) —
SCHEMBL30369685 0.72 NPSR1 (0.44) —
SCHEMBL597339 0.72 NPSR1 (0.44) —
SCHEMBL29293271 0.71 KCNH2 (0.36) —
SCHEMBL18597323 0.68 CYP3A4 (0.42) —
SCHEMBL15701362 0.67 TSHR (0.37) —
SCHEMBL13525418 0.67 HMGCR (0.36) —
SCHEMBL24455111 0.67 SHBG (0.38) —
SCHEMBL21386521 0.65 NPSR1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023133217-A1 2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES REMIX THERAPEUTICS INC. (US) 2023-07-13 — — WO disclosed
Send feedback